Physician profile
Jennifer Willcox
NPI 1851808794
$4,276.56
in general payments reported to CMS, 2019-2025
17 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $34.03 · 2021: $35.66 · 2022: $175 · 2023: $266 · 2024: $1,446 · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718 · Travel and Lodging: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,718.19 |
| Travel and Lodging | $885.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,077.29 | 2022-2025 | Clareon Panoptix Pro, Clareon, Total30 |
| Biotissue Holdings INC. | $963.79 | 2024-2025 | |
| Harrow Eye, LLC | $399.83 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $294.14 | 2022-2024 | Infuse, Miebo, Xiidra |
| Abbvie INC. | $233.40 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $213.63 | 2024-2025 | Acthar |
| Dompe US, INC. | $177.98 | 2024-2025 | Oxervate |
| Thea Pharma INC. | $146.18 | 2025 | Iyuzeh |
| Shire North American Group INC | $142.04 | 2019 | |
| Glaukos Corporation | $115.27 | 2025 | Photrexa Viscous and Photrexa |
| Carl Zeiss Meditec, INC. | $99.27 | 2019 | |
| Ani Pharmaceuticals, INC. | $97.19 | 2024-2025 | Purified Cortrophin Gel |
| Optos, INC. | $85.10 | 2019 | |
| Coopervision INC. | $85.04 | 2019 | |
| Amgen INC. | $59.41 | 2024-2025 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $51.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $35.66 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Willcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.